William D. Waddill, Director: Arrowhead Pharmaceuticals ARWR Planned sale · Filed 25/12/19

Trade details

Type: Planned sale notice
Stock: Arrowhead Pharmaceuticals ARWR
Person: William D. WaddillDirector
Planned sale date: 25/12/19
Filed: 25/12/19

$566K to be sold

Arrowhead Pharmaceuticals trades, last 26 weeks

What else happened in Arrowhead Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/11/19~01/18

William D. Waddill's recent trades

William D. WaddillDirector
Sell10b5-1 planProtagonist Therapeutics
Sell10b5-1 plan
Protagonist Therapeutics
PTGX
$1.1M
9,000 sh
$1.1M
Filed 06/25
Traded 06/23
William D. WaddillDirector
Planned sale10b5-1 planProtagonist Therapeutics
Planned sale10b5-1 plan
Protagonist Therapeutics
PTGX
$1M
9,000 sh
$1M
Filed 06/23
Traded 06/23
William D. WaddillDirector
Sell10b5-1 planProtagonist Therapeutics
Sell10b5-1 plan
Protagonist Therapeutics
PTGX
$969.1K
9,000 sh
$969.1K
Filed 06/11
Traded 06/10
William D. WaddillDirector
Planned sale10b5-1 planProtagonist Therapeutics
Planned sale10b5-1 plan
Protagonist Therapeutics
PTGX
$952.8K
9,000 sh
$952.8K
Filed 06/10
Traded 06/10
William D. WaddillDirector
Sell10b5-1 planProtagonist Therapeutics
Sell10b5-1 plan
Protagonist Therapeutics
PTGX
$896.8K
9,000 sh
$896.8K
Filed 06/01
Traded 05/29

William D. Waddill, Director — plans to sell 8,367 sh of Arrowhead Pharmaceuticals ARWR · $566K · around 12/19 · 10b5-1 plan | Whalegun